nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—embryo—ovarian cancer	0.0334	0.0727	CbGeAlD
Amifostine—ENPP1—uterine cervix—ovarian cancer	0.0281	0.0611	CbGeAlD
Amifostine—ALPL—endometrium—ovarian cancer	0.0276	0.0601	CbGeAlD
Amifostine—ALPPL2—epithelium—ovarian cancer	0.0273	0.0594	CbGeAlD
Amifostine—ALPPL2—uterine cervix—ovarian cancer	0.0271	0.0589	CbGeAlD
Amifostine—ENPP1—decidua—ovarian cancer	0.0267	0.0582	CbGeAlD
Amifostine—ALPPL2—endometrium—ovarian cancer	0.0245	0.0532	CbGeAlD
Amifostine—ENPP1—uterus—ovarian cancer	0.0234	0.0509	CbGeAlD
Amifostine—ALPPL2—gonad—ovarian cancer	0.0227	0.0494	CbGeAlD
Amifostine—ALPPL2—uterus—ovarian cancer	0.0225	0.0491	CbGeAlD
Amifostine—Sensation of warmth—Melphalan—ovarian cancer	0.0219	0.053	CcSEcCtD
Amifostine—ENPP1—female reproductive system—ovarian cancer	0.021	0.0457	CbGeAlD
Amifostine—ALPL—female gonad—ovarian cancer	0.0208	0.0453	CbGeAlD
Amifostine—ALPPL2—female reproductive system—ovarian cancer	0.0203	0.0441	CbGeAlD
Amifostine—ALPPL2—bone marrow—ovarian cancer	0.0191	0.0416	CbGeAlD
Amifostine—ENPP1—female gonad—ovarian cancer	0.0191	0.0416	CbGeAlD
Amifostine—ALPL—testis—ovarian cancer	0.0185	0.0402	CbGeAlD
Amifostine—ALPPL2—female gonad—ovarian cancer	0.0184	0.0401	CbGeAlD
Amifostine—ENPP1—testis—ovarian cancer	0.017	0.0369	CbGeAlD
Amifostine—ALPPL2—testis—ovarian cancer	0.0164	0.0356	CbGeAlD
Amifostine—ALPL—lymph node—ovarian cancer	0.0134	0.0291	CbGeAlD
Amifostine—ENPP1—lymph node—ovarian cancer	0.0123	0.0268	CbGeAlD
Amifostine—ALPL—BDNF signaling pathway—NSF—ovarian cancer	0.0091	0.0711	CbGpPWpGaD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—ovarian cancer	0.00756	0.0591	CbGpPWpGaD
Amifostine—Feeling hot—Melphalan—ovarian cancer	0.0075	0.0182	CcSEcCtD
Amifostine—Rigors—Topotecan—ovarian cancer	0.00736	0.0179	CcSEcCtD
Amifostine—Convulsion—Altretamine—ovarian cancer	0.0072	0.0174	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—SOD1—ovarian cancer	0.00641	0.0501	CbGpPWpGaD
Amifostine—Myocardial ischaemia—Vinorelbine—ovarian cancer	0.0064	0.0155	CcSEcCtD
Amifostine—Chest tightness—Docetaxel—ovarian cancer	0.00625	0.0152	CcSEcCtD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—FASN—ovarian cancer	0.00538	0.0421	CbGpPWpGaD
Amifostine—Supraventricular tachycardia—Paclitaxel—ovarian cancer	0.00528	0.0128	CcSEcCtD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—ovarian cancer	0.00511	0.04	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—IKBKG—ovarian cancer	0.00484	0.0378	CbGpPWpGaD
Amifostine—Atrial fibrillation—Melphalan—ovarian cancer	0.00451	0.0109	CcSEcCtD
Amifostine—Anaphylactoid reaction—Topotecan—ovarian cancer	0.00451	0.0109	CcSEcCtD
Amifostine—Dizziness—Altretamine—ovarian cancer	0.00448	0.0109	CcSEcCtD
Amifostine—Supraventricular tachycardia—Docetaxel—ovarian cancer	0.00447	0.0108	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Chlorambucil—ovarian cancer	0.00441	0.0107	CcSEcCtD
Amifostine—Vomiting—Altretamine—ovarian cancer	0.00431	0.0105	CcSEcCtD
Amifostine—Myocardial ischaemia—Paclitaxel—ovarian cancer	0.0043	0.0104	CcSEcCtD
Amifostine—Rigors—Paclitaxel—ovarian cancer	0.00424	0.0103	CcSEcCtD
Amifostine—Cardiac arrest—Topotecan—ovarian cancer	0.00415	0.0101	CcSEcCtD
Amifostine—Extrasystoles—Paclitaxel—ovarian cancer	0.00411	0.00997	CcSEcCtD
Amifostine—Cardiac arrest—Melphalan—ovarian cancer	0.00406	0.00985	CcSEcCtD
Amifostine—Nausea—Altretamine—ovarian cancer	0.00403	0.00976	CcSEcCtD
Amifostine—Chest discomfort—Paclitaxel—ovarian cancer	0.00391	0.00948	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—MMP2—ovarian cancer	0.00378	0.0296	CbGpPWpGaD
Amifostine—Hypocalcaemia—Paclitaxel—ovarian cancer	0.00378	0.00916	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00375	0.00908	CcSEcCtD
Amifostine—Body temperature increased—Carboplatin—ovarian cancer	0.0037	0.00898	CcSEcCtD
Amifostine—Myocardial ischaemia—Docetaxel—ovarian cancer	0.00365	0.00884	CcSEcCtD
Amifostine—Rigors—Docetaxel—ovarian cancer	0.00359	0.00871	CcSEcCtD
Amifostine—Chest discomfort—Docetaxel—ovarian cancer	0.00331	0.00803	CcSEcCtD
Amifostine—Erythema multiforme—Chlorambucil—ovarian cancer	0.00321	0.00777	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—SLC2A1—ovarian cancer	0.00314	0.0246	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CASP3—ovarian cancer	0.00301	0.0235	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—MMP9—ovarian cancer	0.00291	0.0228	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MMP9—ovarian cancer	0.00284	0.0222	CbGpPWpGaD
Amifostine—Acute coronary syndrome—Vinorelbine—ovarian cancer	0.00284	0.00688	CcSEcCtD
Amifostine—Myocardial infarction—Vinorelbine—ovarian cancer	0.00282	0.00684	CcSEcCtD
Amifostine—Flushing—Melphalan—ovarian cancer	0.00274	0.00665	CcSEcCtD
Amifostine—Chills—Topotecan—ovarian cancer	0.00271	0.00657	CcSEcCtD
Amifostine—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00266	0.00645	CcSEcCtD
Amifostine—Atrial fibrillation—Paclitaxel—ovarian cancer	0.00265	0.00642	CcSEcCtD
Amifostine—Arrhythmia—Melphalan—ovarian cancer	0.00264	0.0064	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—VEGFA—ovarian cancer	0.00262	0.0205	CbGpPWpGaD
Amifostine—Convulsion—Chlorambucil—ovarian cancer	0.00256	0.0062	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—STAT3—ovarian cancer	0.00253	0.0198	CbGpPWpGaD
Amifostine—Feeling hot—Epirubicin—ovarian cancer	0.00252	0.00611	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—MMP9—ovarian cancer	0.00248	0.0194	CbGpPWpGaD
Amifostine—Ill-defined disorder—Topotecan—ovarian cancer	0.00244	0.00591	CcSEcCtD
Amifostine—Rigors—Epirubicin—ovarian cancer	0.00242	0.00587	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—MAPK3—ovarian cancer	0.00241	0.0189	CbGpPWpGaD
Amifostine—Flushing—Vinorelbine—ovarian cancer	0.0024	0.00581	CcSEcCtD
Amifostine—Cardiac arrest—Paclitaxel—ovarian cancer	0.00239	0.00579	CcSEcCtD
Amifostine—Malaise—Topotecan—ovarian cancer	0.00237	0.00575	CcSEcCtD
Amifostine—Feeling hot—Doxorubicin—ovarian cancer	0.00233	0.00565	CcSEcCtD
Amifostine—Arrhythmia—Vinorelbine—ovarian cancer	0.00231	0.00559	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—MAPK1—ovarian cancer	0.0023	0.018	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—EGFR—ovarian cancer	0.0023	0.018	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—APC—ovarian cancer	0.00229	0.0179	CbGpPWpGaD
Amifostine—ENPP1—Disease—HSD17B6—ovarian cancer	0.00226	0.0177	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00226	0.00548	CcSEcCtD
Amifostine—Atrial fibrillation—Docetaxel—ovarian cancer	0.00225	0.00545	CcSEcCtD
Amifostine—Rigors—Doxorubicin—ovarian cancer	0.00224	0.00543	CcSEcCtD
Amifostine—Chest pain—Topotecan—ovarian cancer	0.00224	0.00542	CcSEcCtD
Amifostine—Convulsion—Melphalan—ovarian cancer	0.00223	0.00541	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—VEGFA—ovarian cancer	0.00222	0.0174	CbGpPWpGaD
Amifostine—Discomfort—Topotecan—ovarian cancer	0.00221	0.00536	CcSEcCtD
Amifostine—Chest pain—Melphalan—ovarian cancer	0.00219	0.00531	CcSEcCtD
Amifostine—Hypocalcaemia—Epirubicin—ovarian cancer	0.00216	0.00524	CcSEcCtD
Amifostine—Anaphylactic shock—Topotecan—ovarian cancer	0.00214	0.0052	CcSEcCtD
Amifostine—Anaphylactic shock—Melphalan—ovarian cancer	0.0021	0.00509	CcSEcCtD
Amifostine—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00209	0.00506	CcSEcCtD
Amifostine—Tachycardia—Melphalan—ovarian cancer	0.00205	0.00497	CcSEcCtD
Amifostine—Malaise—Vinorelbine—ovarian cancer	0.00203	0.00492	CcSEcCtD
Amifostine—Hypocalcaemia—Doxorubicin—ovarian cancer	0.002	0.00485	CcSEcCtD
Amifostine—Feeling abnormal—Chlorambucil—ovarian cancer	0.00199	0.00481	CcSEcCtD
Amifostine—Hiccups—Epirubicin—ovarian cancer	0.00198	0.00479	CcSEcCtD
Amifostine—Hypotension—Melphalan—ovarian cancer	0.00196	0.00476	CcSEcCtD
Amifostine—Hypertension—Vinorelbine—ovarian cancer	0.00194	0.00471	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00192	0.00465	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00192	0.00465	CcSEcCtD
Amifostine—Urticaria—Chlorambucil—ovarian cancer	0.00191	0.00464	CcSEcCtD
Amifostine—Chest pain—Vinorelbine—ovarian cancer	0.00191	0.00464	CcSEcCtD
Amifostine—Dyspnoea—Topotecan—ovarian cancer	0.00191	0.00464	CcSEcCtD
Amifostine—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.00191	0.00462	CcSEcCtD
Amifostine—Body temperature increased—Chlorambucil—ovarian cancer	0.0019	0.00462	CcSEcCtD
Amifostine—Renal failure—Paclitaxel—ovarian cancer	0.0019	0.00461	CcSEcCtD
Amifostine—Myocardial infarction—Paclitaxel—ovarian cancer	0.0019	0.0046	CcSEcCtD
Amifostine—Discomfort—Vinorelbine—ovarian cancer	0.00189	0.00458	CcSEcCtD
Amifostine—Dyspnoea—Melphalan—ovarian cancer	0.00187	0.00454	CcSEcCtD
Amifostine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00183	0.00445	CcSEcCtD
Amifostine—Hiccups—Doxorubicin—ovarian cancer	0.00183	0.00444	CcSEcCtD
Amifostine—ENPP1—Disease—CHMP4C—ovarian cancer	0.00181	0.0141	CbGpPWpGaD
Amifostine—Tachycardia—Vinorelbine—ovarian cancer	0.00179	0.00434	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PIK3CG—ovarian cancer	0.00179	0.014	CbGpPWpGaD
Amifostine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00178	0.0043	CcSEcCtD
Amifostine—Bradycardia—Paclitaxel—ovarian cancer	0.00177	0.00429	CcSEcCtD
Amifostine—Feeling abnormal—Topotecan—ovarian cancer	0.00177	0.00429	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—MTOR—ovarian cancer	0.00175	0.0137	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NME2—ovarian cancer	0.00173	0.0135	CbGpPWpGaD
Amifostine—Hypotension—Vinorelbine—ovarian cancer	0.00171	0.00416	CcSEcCtD
Amifostine—Pruritus—Chlorambucil—ovarian cancer	0.0017	0.00413	CcSEcCtD
Amifostine—Urticaria—Topotecan—ovarian cancer	0.0017	0.00413	CcSEcCtD
Amifostine—Body temperature increased—Topotecan—ovarian cancer	0.0017	0.00411	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—AKT1—ovarian cancer	0.00167	0.0131	CbGpPWpGaD
Amifostine—Urticaria—Melphalan—ovarian cancer	0.00167	0.00405	CcSEcCtD
Amifostine—Erythema multiforme—Paclitaxel—ovarian cancer	0.00164	0.00398	CcSEcCtD
Amifostine—Dyspnoea—Vinorelbine—ovarian cancer	0.00164	0.00397	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—AKT1—ovarian cancer	0.00163	0.0127	CbGpPWpGaD
Amifostine—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00163	0.00394	CcSEcCtD
Amifostine—Acute coronary syndrome—Docetaxel—ovarian cancer	0.00162	0.00392	CcSEcCtD
Amifostine—Renal failure—Docetaxel—ovarian cancer	0.00161	0.00391	CcSEcCtD
Amifostine—Flushing—Paclitaxel—ovarian cancer	0.00161	0.00391	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—CASP3—ovarian cancer	0.00161	0.0126	CbGpPWpGaD
Amifostine—Myocardial infarction—Docetaxel—ovarian cancer	0.00161	0.0039	CcSEcCtD
Amifostine—Hypersensitivity—Topotecan—ovarian cancer	0.00158	0.00383	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PIK3CD—ovarian cancer	0.00157	0.0123	CbGpPWpGaD
Amifostine—ENPP1—Disease—BCL9—ovarian cancer	0.00157	0.0123	CbGpPWpGaD
Amifostine—Chills—Paclitaxel—ovarian cancer	0.00156	0.00378	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—CTNNB1—ovarian cancer	0.00155	0.0121	CbGpPWpGaD
Amifostine—Arrhythmia—Paclitaxel—ovarian cancer	0.00155	0.00376	CcSEcCtD
Amifostine—Hypersensitivity—Melphalan—ovarian cancer	0.00155	0.00375	CcSEcCtD
Amifostine—Vomiting—Chlorambucil—ovarian cancer	0.00153	0.00371	CcSEcCtD
Amifostine—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00152	0.00369	CcSEcCtD
Amifostine—Pruritus—Topotecan—ovarian cancer	0.00152	0.00368	CcSEcCtD
Amifostine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00151	0.00367	CcSEcCtD
Amifostine—Pruritus—Melphalan—ovarian cancer	0.00149	0.0036	CcSEcCtD
Amifostine—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00148	0.0036	CcSEcCtD
Amifostine—Urticaria—Vinorelbine—ovarian cancer	0.00146	0.00353	CcSEcCtD
Amifostine—Body temperature increased—Vinorelbine—ovarian cancer	0.00145	0.00352	CcSEcCtD
Amifostine—Nausea—Chlorambucil—ovarian cancer	0.00143	0.00347	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—AKT1—ovarian cancer	0.00142	0.0111	CbGpPWpGaD
Amifostine—Dizziness—Topotecan—ovarian cancer	0.00142	0.00344	CcSEcCtD
Amifostine—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00141	0.00341	CcSEcCtD
Amifostine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.0014	0.0034	CcSEcCtD
Amifostine—Erythema multiforme—Docetaxel—ovarian cancer	0.00139	0.00338	CcSEcCtD
Amifostine—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00137	0.00333	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PIK3CB—ovarian cancer	0.00137	0.0107	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MTOR—ovarian cancer	0.00137	0.0107	CbGpPWpGaD
Amifostine—Flushing—Docetaxel—ovarian cancer	0.00137	0.00331	CcSEcCtD
Amifostine—Cardiac arrest—Epirubicin—ovarian cancer	0.00137	0.00331	CcSEcCtD
Amifostine—Vomiting—Topotecan—ovarian cancer	0.00136	0.00331	CcSEcCtD
Amifostine—Malaise—Paclitaxel—ovarian cancer	0.00136	0.00331	CcSEcCtD
Amifostine—Syncope—Paclitaxel—ovarian cancer	0.00136	0.00329	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—STAT3—ovarian cancer	0.00135	0.0106	CbGpPWpGaD
Amifostine—Rash—Topotecan—ovarian cancer	0.00135	0.00328	CcSEcCtD
Amifostine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00135	0.00328	CcSEcCtD
Amifostine—Dermatitis—Topotecan—ovarian cancer	0.00135	0.00328	CcSEcCtD
Amifostine—Vomiting—Melphalan—ovarian cancer	0.00134	0.00324	CcSEcCtD
Amifostine—Loss of consciousness—Paclitaxel—ovarian cancer	0.00133	0.00322	CcSEcCtD
Amifostine—Rash—Melphalan—ovarian cancer	0.00132	0.00321	CcSEcCtD
Amifostine—Dermatitis—Melphalan—ovarian cancer	0.00132	0.00321	CcSEcCtD
Amifostine—Chills—Docetaxel—ovarian cancer	0.00132	0.0032	CcSEcCtD
Amifostine—Arrhythmia—Docetaxel—ovarian cancer	0.00132	0.00319	CcSEcCtD
Amifostine—Convulsion—Paclitaxel—ovarian cancer	0.00131	0.00318	CcSEcCtD
Amifostine—Hypertension—Paclitaxel—ovarian cancer	0.00131	0.00317	CcSEcCtD
Amifostine—Pruritus—Vinorelbine—ovarian cancer	0.0013	0.00315	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—MAPK3—ovarian cancer	0.00129	0.0101	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00129	0.00313	CcSEcCtD
Amifostine—Chest pain—Paclitaxel—ovarian cancer	0.00129	0.00312	CcSEcCtD
Amifostine—Nausea—Topotecan—ovarian cancer	0.00127	0.00309	CcSEcCtD
Amifostine—Discomfort—Paclitaxel—ovarian cancer	0.00127	0.00308	CcSEcCtD
Amifostine—Cardiac arrest—Doxorubicin—ovarian cancer	0.00126	0.00306	CcSEcCtD
Amifostine—Nausea—Melphalan—ovarian cancer	0.00125	0.00302	CcSEcCtD
Amifostine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00123	0.00299	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—MAPK1—ovarian cancer	0.00123	0.00962	CbGpPWpGaD
Amifostine—Shock—Paclitaxel—ovarian cancer	0.00121	0.00294	CcSEcCtD
Amifostine—Dizziness—Vinorelbine—ovarian cancer	0.00121	0.00294	CcSEcCtD
Amifostine—Tachycardia—Paclitaxel—ovarian cancer	0.0012	0.00292	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.0012	0.0029	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PTEN—ovarian cancer	0.00118	0.00925	CbGpPWpGaD
Amifostine—Vomiting—Vinorelbine—ovarian cancer	0.00117	0.00283	CcSEcCtD
Amifostine—ENPP1—Disease—PPP1CC—ovarian cancer	0.00117	0.00911	CbGpPWpGaD
Amifostine—Rash—Vinorelbine—ovarian cancer	0.00116	0.0028	CcSEcCtD
Amifostine—Dermatitis—Vinorelbine—ovarian cancer	0.00116	0.0028	CcSEcCtD
Amifostine—Hypotension—Paclitaxel—ovarian cancer	0.00115	0.0028	CcSEcCtD
Amifostine—Syncope—Docetaxel—ovarian cancer	0.00115	0.00279	CcSEcCtD
Amifostine—Loss of consciousness—Docetaxel—ovarian cancer	0.00113	0.00273	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYTB—ovarian cancer	0.00112	0.00873	CbGpPWpGaD
Amifostine—Convulsion—Docetaxel—ovarian cancer	0.00111	0.00269	CcSEcCtD
Amifostine—Hypertension—Docetaxel—ovarian cancer	0.00111	0.00268	CcSEcCtD
Amifostine—Dyspnoea—Paclitaxel—ovarian cancer	0.0011	0.00267	CcSEcCtD
Amifostine—Somnolence—Paclitaxel—ovarian cancer	0.0011	0.00266	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.0011	0.00266	CcSEcCtD
Amifostine—Chest pain—Docetaxel—ovarian cancer	0.00109	0.00265	CcSEcCtD
Amifostine—Nausea—Vinorelbine—ovarian cancer	0.00109	0.00264	CcSEcCtD
Amifostine—Renal failure—Epirubicin—ovarian cancer	0.00109	0.00264	CcSEcCtD
Amifostine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00105	0.00254	CcSEcCtD
Amifostine—Shock—Docetaxel—ovarian cancer	0.00103	0.0025	CcSEcCtD
Amifostine—Tachycardia—Docetaxel—ovarian cancer	0.00102	0.00248	CcSEcCtD
Amifostine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00102	0.00247	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00101	0.00246	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MAPK3—ovarian cancer	0.00101	0.00791	CbGpPWpGaD
Amifostine—Bradycardia—Epirubicin—ovarian cancer	0.00101	0.00245	CcSEcCtD
Amifostine—Renal failure—Doxorubicin—ovarian cancer	0.00101	0.00244	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—HRAS—ovarian cancer	0.000988	0.00773	CbGpPWpGaD
Amifostine—Urticaria—Paclitaxel—ovarian cancer	0.00098	0.00238	CcSEcCtD
Amifostine—Hypotension—Docetaxel—ovarian cancer	0.000977	0.00237	CcSEcCtD
Amifostine—ENPP1—Metabolism—PPP1CC—ovarian cancer	0.000976	0.00763	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—BRIP1—ovarian cancer	0.000976	0.00763	CbGpPWpGaD
Amifostine—Body temperature increased—Paclitaxel—ovarian cancer	0.000976	0.00237	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—MAPK1—ovarian cancer	0.000962	0.00752	CbGpPWpGaD
Amifostine—Erythema multiforme—Epirubicin—ovarian cancer	0.000939	0.00228	CcSEcCtD
Amifostine—Bradycardia—Doxorubicin—ovarian cancer	0.000935	0.00227	CcSEcCtD
Amifostine—Dyspnoea—Docetaxel—ovarian cancer	0.000933	0.00226	CcSEcCtD
Amifostine—Somnolence—Docetaxel—ovarian cancer	0.00093	0.00225	CcSEcCtD
Amifostine—Flushing—Epirubicin—ovarian cancer	0.000922	0.00223	CcSEcCtD
Amifostine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000909	0.0022	CcSEcCtD
Amifostine—Chills—Epirubicin—ovarian cancer	0.000891	0.00216	CcSEcCtD
Amifostine—Arrhythmia—Epirubicin—ovarian cancer	0.000887	0.00215	CcSEcCtD
Amifostine—ENPP1—Disease—HDAC6—ovarian cancer	0.000883	0.0069	CbGpPWpGaD
Amifostine—Pruritus—Paclitaxel—ovarian cancer	0.000873	0.00212	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—AKT1—ovarian cancer	0.000873	0.00682	CbGpPWpGaD
Amifostine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000869	0.00211	CcSEcCtD
Amifostine—Feeling abnormal—Docetaxel—ovarian cancer	0.000862	0.00209	CcSEcCtD
Amifostine—Flushing—Doxorubicin—ovarian cancer	0.000853	0.00207	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PIK3CA—ovarian cancer	0.000835	0.00653	CbGpPWpGaD
Amifostine—Body temperature increased—Docetaxel—ovarian cancer	0.000827	0.002	CcSEcCtD
Amifostine—Chills—Doxorubicin—ovarian cancer	0.000825	0.002	CcSEcCtD
Amifostine—Arrhythmia—Doxorubicin—ovarian cancer	0.000821	0.00199	CcSEcCtD
Amifostine—Dizziness—Paclitaxel—ovarian cancer	0.000816	0.00198	CcSEcCtD
Amifostine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000802	0.00194	CcSEcCtD
Amifostine—Vomiting—Paclitaxel—ovarian cancer	0.000785	0.0019	CcSEcCtD
Amifostine—Malaise—Epirubicin—ovarian cancer	0.00078	0.00189	CcSEcCtD
Amifostine—Rash—Paclitaxel—ovarian cancer	0.000778	0.00189	CcSEcCtD
Amifostine—Dermatitis—Paclitaxel—ovarian cancer	0.000777	0.00188	CcSEcCtD
Amifostine—Syncope—Epirubicin—ovarian cancer	0.000775	0.00188	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—HRAS—ovarian cancer	0.000772	0.00604	CbGpPWpGaD
Amifostine—Hypersensitivity—Docetaxel—ovarian cancer	0.000771	0.00187	CcSEcCtD
Amifostine—ENPP1—Disease—XIAP—ovarian cancer	0.000766	0.00599	CbGpPWpGaD
Amifostine—Loss of consciousness—Epirubicin—ovarian cancer	0.00076	0.00184	CcSEcCtD
Amifostine—Convulsion—Epirubicin—ovarian cancer	0.000749	0.00182	CcSEcCtD
Amifostine—Hypertension—Epirubicin—ovarian cancer	0.000746	0.00181	CcSEcCtD
Amifostine—ENPP1—Disease—SMARCA4—ovarian cancer	0.000746	0.00583	CbGpPWpGaD
Amifostine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000742	0.0018	CcSEcCtD
Amifostine—Pruritus—Docetaxel—ovarian cancer	0.00074	0.00179	CcSEcCtD
Amifostine—Chest pain—Epirubicin—ovarian cancer	0.000736	0.00178	CcSEcCtD
Amifostine—Nausea—Paclitaxel—ovarian cancer	0.000733	0.00178	CcSEcCtD
Amifostine—ENPP1—Disease—EREG—ovarian cancer	0.000728	0.00569	CbGpPWpGaD
Amifostine—Discomfort—Epirubicin—ovarian cancer	0.000727	0.00176	CcSEcCtD
Amifostine—Malaise—Doxorubicin—ovarian cancer	0.000721	0.00175	CcSEcCtD
Amifostine—Syncope—Doxorubicin—ovarian cancer	0.000717	0.00174	CcSEcCtD
Amifostine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000706	0.00171	CcSEcCtD
Amifostine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000703	0.0017	CcSEcCtD
Amifostine—Shock—Epirubicin—ovarian cancer	0.000694	0.00168	CcSEcCtD
Amifostine—Convulsion—Doxorubicin—ovarian cancer	0.000693	0.00168	CcSEcCtD
Amifostine—Dizziness—Docetaxel—ovarian cancer	0.000692	0.00168	CcSEcCtD
Amifostine—Hypertension—Doxorubicin—ovarian cancer	0.000691	0.00167	CcSEcCtD
Amifostine—Tachycardia—Epirubicin—ovarian cancer	0.000689	0.00167	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—AKT1—ovarian cancer	0.000682	0.00533	CbGpPWpGaD
Amifostine—Chest pain—Doxorubicin—ovarian cancer	0.000681	0.00165	CcSEcCtD
Amifostine—Discomfort—Doxorubicin—ovarian cancer	0.000673	0.00163	CcSEcCtD
Amifostine—Vomiting—Docetaxel—ovarian cancer	0.000665	0.00161	CcSEcCtD
Amifostine—Rash—Docetaxel—ovarian cancer	0.00066	0.0016	CcSEcCtD
Amifostine—Hypotension—Epirubicin—ovarian cancer	0.000659	0.0016	CcSEcCtD
Amifostine—Dermatitis—Docetaxel—ovarian cancer	0.000659	0.0016	CcSEcCtD
Amifostine—ENPP1—Metabolism—YAP1—ovarian cancer	0.000655	0.00512	CbGpPWpGaD
Amifostine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000653	0.00158	CcSEcCtD
Amifostine—Shock—Doxorubicin—ovarian cancer	0.000642	0.00156	CcSEcCtD
Amifostine—Tachycardia—Doxorubicin—ovarian cancer	0.000637	0.00154	CcSEcCtD
Amifostine—ENPP1—Disease—FASN—ovarian cancer	0.000637	0.00498	CbGpPWpGaD
Amifostine—ENPP1—Disease—PARP1—ovarian cancer	0.000634	0.00496	CbGpPWpGaD
Amifostine—Dyspnoea—Epirubicin—ovarian cancer	0.000629	0.00153	CcSEcCtD
Amifostine—Somnolence—Epirubicin—ovarian cancer	0.000627	0.00152	CcSEcCtD
Amifostine—Nausea—Docetaxel—ovarian cancer	0.000621	0.00151	CcSEcCtD
Amifostine—Hypotension—Doxorubicin—ovarian cancer	0.00061	0.00148	CcSEcCtD
Amifostine—ENPP1—Disease—SLC2A1—ovarian cancer	0.000605	0.00473	CbGpPWpGaD
Amifostine—Dyspnoea—Doxorubicin—ovarian cancer	0.000582	0.00141	CcSEcCtD
Amifostine—Feeling abnormal—Epirubicin—ovarian cancer	0.000581	0.00141	CcSEcCtD
Amifostine—Somnolence—Doxorubicin—ovarian cancer	0.00058	0.00141	CcSEcCtD
Amifostine—Urticaria—Epirubicin—ovarian cancer	0.000561	0.00136	CcSEcCtD
Amifostine—Body temperature increased—Epirubicin—ovarian cancer	0.000558	0.00135	CcSEcCtD
Amifostine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000538	0.0013	CcSEcCtD
Amifostine—ENPP1—Metabolism—FASN—ovarian cancer	0.000534	0.00417	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC5A5—ovarian cancer	0.000525	0.0041	CbGpPWpGaD
Amifostine—Hypersensitivity—Epirubicin—ovarian cancer	0.00052	0.00126	CcSEcCtD
Amifostine—Urticaria—Doxorubicin—ovarian cancer	0.000519	0.00126	CcSEcCtD
Amifostine—Body temperature increased—Doxorubicin—ovarian cancer	0.000516	0.00125	CcSEcCtD
Amifostine—ENPP1—Disease—PPP2R1A—ovarian cancer	0.000515	0.00402	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC2A1—ovarian cancer	0.000507	0.00396	CbGpPWpGaD
Amifostine—Pruritus—Epirubicin—ovarian cancer	0.000499	0.00121	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP1B1—ovarian cancer	0.000486	0.0038	CbGpPWpGaD
Amifostine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000481	0.00117	CcSEcCtD
Amifostine—Dizziness—Epirubicin—ovarian cancer	0.000467	0.00113	CcSEcCtD
Amifostine—Pruritus—Doxorubicin—ovarian cancer	0.000462	0.00112	CcSEcCtD
Amifostine—Vomiting—Epirubicin—ovarian cancer	0.000449	0.00109	CcSEcCtD
Amifostine—Rash—Epirubicin—ovarian cancer	0.000445	0.00108	CcSEcCtD
Amifostine—Dermatitis—Epirubicin—ovarian cancer	0.000444	0.00108	CcSEcCtD
Amifostine—Dizziness—Doxorubicin—ovarian cancer	0.000432	0.00105	CcSEcCtD
Amifostine—ENPP1—Metabolism—PPP2R1A—ovarian cancer	0.000431	0.00337	CbGpPWpGaD
Amifostine—Nausea—Epirubicin—ovarian cancer	0.000419	0.00102	CcSEcCtD
Amifostine—Vomiting—Doxorubicin—ovarian cancer	0.000415	0.00101	CcSEcCtD
Amifostine—Rash—Doxorubicin—ovarian cancer	0.000412	0.000998	CcSEcCtD
Amifostine—Dermatitis—Doxorubicin—ovarian cancer	0.000411	0.000997	CcSEcCtD
Amifostine—ENPP1—Disease—TERT—ovarian cancer	0.000409	0.0032	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ABCB1—ovarian cancer	0.0004	0.00313	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—TYMS—ovarian cancer	0.000393	0.00307	CbGpPWpGaD
Amifostine—Nausea—Doxorubicin—ovarian cancer	0.000388	0.00094	CcSEcCtD
Amifostine—ENPP1—Disease—CAV1—ovarian cancer	0.000378	0.00296	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL6ST—ovarian cancer	0.000358	0.0028	CbGpPWpGaD
Amifostine—ENPP1—Disease—APC—ovarian cancer	0.000344	0.00269	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CAV1—ovarian cancer	0.000317	0.00248	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CD—ovarian cancer	0.000303	0.00237	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CG—ovarian cancer	0.000288	0.00226	CbGpPWpGaD
Amifostine—ENPP1—Disease—ERBB2—ovarian cancer	0.000267	0.00209	CbGpPWpGaD
Amifostine—ENPP1—Disease—MTOR—ovarian cancer	0.000264	0.00206	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CB—ovarian cancer	0.000264	0.00206	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CD—ovarian cancer	0.000254	0.00198	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN1B—ovarian cancer	0.000248	0.00194	CbGpPWpGaD
Amifostine—ENPP1—Disease—CTNNB1—ovarian cancer	0.000234	0.00183	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTEN—ovarian cancer	0.000228	0.00178	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CB—ovarian cancer	0.000221	0.00173	CbGpPWpGaD
Amifostine—ENPP1—Disease—STAT3—ovarian cancer	0.000204	0.00159	CbGpPWpGaD
Amifostine—ENPP1—Disease—NRAS—ovarian cancer	0.000203	0.00159	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAPK3—ovarian cancer	0.000195	0.00152	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTEN—ovarian cancer	0.000191	0.00149	CbGpPWpGaD
Amifostine—ENPP1—Disease—MYC—ovarian cancer	0.00019	0.00148	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAPK1—ovarian cancer	0.000185	0.00145	CbGpPWpGaD
Amifostine—ENPP1—Disease—EGFR—ovarian cancer	0.000185	0.00145	CbGpPWpGaD
Amifostine—ENPP1—Disease—KRAS—ovarian cancer	0.000175	0.00137	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CA—ovarian cancer	0.000161	0.00126	CbGpPWpGaD
Amifostine—ENPP1—Disease—HRAS—ovarian cancer	0.000149	0.00116	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL6—ovarian cancer	0.000142	0.00111	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CA—ovarian cancer	0.000135	0.00105	CbGpPWpGaD
Amifostine—ENPP1—Disease—AKT1—ovarian cancer	0.000131	0.00103	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AKT1—ovarian cancer	0.00011	0.000861	CbGpPWpGaD
